Tesamorelin wiki: learn what tesamorelin is, how research studies use it, FDA-approved uses, side effects, and how it compares to AOD-9604.
Tesamorelin is a synthetic peptide that mimics growth hormone-releasing hormone (GHRH). It is FDA-approved under the brand name Egrifta for reducing excess abdominal fat in adults with HIV-associated lipodystrophy. Tesamorelin is not approved for general weight loss, bodybuilding, or anti-aging use in the United States.
What Is Tesamorelin?
Tesamorelin is a 44-amino-acid peptide. It binds to GHRH receptors in the pituitary gland and stimulates the body's own growth hormone release. This makes it different from exogenous growth hormone injections, which deliver GH directly into the bloodstream.
For Spanish-speaking readers, the search 'tesamorelin que es' means 'what is tesamorelin.' The answer is the same: it is a prescription GHRH analog, not a dietary supplement or a natural compound. Some people also search 'tesamorelin in spanish' or 'tesamorelin en español' to find the same basic definition.
Tesamorelin peptide research has focused on its effects on visceral adipose tissue (VAT). VAT is the deep belly fat linked to metabolic and cardiovascular risk. In clinical trials, tesamorelin reduced VAT in patients with HIV-associated lipodystrophy.
Tesamorelin Research and Studies
Most human tesamorelin studies come from Phase 3 trials in HIV-positive adults with lipodystrophy. These trials found that daily tesamorelin injections reduced visceral fat by roughly 15% to 20% over 6 to 12 months.
In one 26-week randomized trial, tesamorelin reduced VAT by about 15.6% compared with placebo. A 52-week extension showed that the reduction was maintained with continued treatment. Some tesamorelin research also looked at liver fat, cognitive function, and muscle mass.
Results outside the approved lipodystrophy population have been mixed. Tesamorelin therapy is not a proven treatment for obesity in the general population. It is also not a cure for metabolic disease.
Researchers sometimes compare aod 9604 vs tesamorelin because both peptides are studied for fat loss. AOD-9604 is a modified fragment of human growth hormone, while tesamorelin works upstream by raising endogenous GH.
When people ask about aod-9604 peptide vs tesamorelin, they are usually comparing how each peptide affects fat metabolism. Human data for AOD-9604 is much thinner than for tesamorelin.
Some experimental protocols combine aod 9604 with tesamorelin. However, a tesamorelin aod-9604 stack has not been validated in large randomized trials, and stacking peptides can increase side effects.
Approved Tesamorelin Therapy and Dosing
The FDA-approved dose of tesamorelin is 2 mg injected subcutaneously once daily. The injection site should be rotated to reduce irritation. Vials must be stored refrigerated and reconstituted with sterile water.
A healthcare professional should monitor IGF-1 levels and glucose control during treatment. If IGF-1 rises too high, the dose may be reduced or stopped. Tesamorelin therapy is not a first-line option for weight loss.
It is specifically for HIV-associated lipodystrophy, a condition where fat redistributes from the limbs and face to the abdomen. Treatment effects usually reverse after stopping tesamorelin. In studies, visceral fat returned toward baseline within a few months of discontinuation.
Side Effects and Safety
Common tesamorelin side effects include injection-site reactions, joint pain, muscle pain, and swelling. Some patients develop increased IGF-1 levels, which may raise theoretical risks with long-term use.
Tesamorelin is contraindicated in people with active malignancy, pituitary surgery history, or hypopituitarism. It is not recommended during pregnancy or breastfeeding. Injection site rotation helps reduce lipohypertrophy.
Some patients develop antibodies to growth hormone, but the clinical significance is unclear. Tesamorelin is a prescription drug in the United States, not an over-the-counter supplement. Anyone considering tesamorelin should consult a healthcare professional and use it only under medical supervision.
Tesamorelin vs AOD-9604: Key Differences
People often search for a tesamorelin wiki to compare it with other fat-loss peptides. The table below summarizes the main differences between tesamorelin and AOD-9604.
| Feature | Tesamorelin | AOD-9604 |
|---|---|---|
| FDA approval | Approved for HIV-associated lipodystrophy | Not approved for any human use |
| Mechanism | GHRH analog; raises endogenous growth hormone | Modified HGH fragment; may affect fat metabolism directly |
| Route | Subcutaneous injection | Subcutaneous injection (research only) |
| Human data | Phase 3 trials in lipodystrophy | Limited, mostly small studies |
| Typical research interest | Visceral fat reduction, IGF-1 effects | Fat loss without GH release |
This comparison shows why tesamorelin has stronger human evidence than AOD-9604. Tesamorelin also has more regulatory and safety requirements because it is an approved prescription drug.
Legal Status and Where People Find Tesamorelin
Tesamorelin is a prescription medication in the US. It is not a controlled substance like anabolic steroids, but importing or selling unapproved tesamorelin is illegal.
Online vendors often sell 'tesamorelin research peptide' for laboratory use. These products are not FDA-approved for human consumption. Their purity and sterility are not guaranteed.
If you see a tesamorelin wiki page claiming it is a safe supplement for weight loss, that claim is not supported by US law or clinical evidence. Consult a doctor before using any peptide.
Frequently Asked Questions
Is tesamorelin FDA approved?
Yes. Tesamorelin is FDA-approved under the brand name Egrifta for HIV-associated lipodystrophy. It is not approved for general weight loss or cosmetic fat reduction.
What does tesamorelin do for visceral fat?
Tesamorelin stimulates growth hormone release, which can reduce visceral adipose tissue in patients with HIV-associated lipodystrophy. Clinical trials show about 15% to 20% reduction in visceral fat over 6 to 12 months. Effects generally reverse after stopping treatment.
Can I buy tesamorelin online without a prescription?
In the US, tesamorelin is a prescription drug, so buying it without a prescription is illegal. Online 'research peptide' versions are not FDA-approved for human use and may be unsafe. Talk to a healthcare professional if you are considering tesamorelin.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.